Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease

BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a critical global health burden, driven by rising prevalence rates and earlier disease onset. Current therapeutic strategies remain limited to lifestyle interventions, with no approved pharmacotherapies targeti...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Ting Zhou, Ziwen Jin, Rilei Jiang, Weiwei Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Subjects:	metabolic dysfunction-associated steatotic liver disease gut microbiota Traditional Chinese Medicine gut-liver axis bile acid metabolism
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1600439/full